Skip to main content
. 2020 Feb 27;15:43. doi: 10.1186/s13019-020-1079-4

Table 3.

Site of recurrence

Patients experienced recurrence after PM (n = 32) Patients experienced recurrence after SBRT (n = 18)
Lung alone 11 (34%) 6 (33%)
Distant metastasis besides lung 13 (41%) 6 (33%)
Local relapse of primary tumor or regional lymph nodes 3 (9%) 5 (28%)
Local progression of PM alone 4 (13%) 0 (0%)
Local progression of PM and distant metastasis 1 (3%) 1 (6%)

PM pulmonary metastasectomy, SBRT stereotactic body radiation therapy